Ryburn Pharmacy (ripponden) Limited

POWER SEARCH PRICING

SOLUTIONS

ryburn pharmacy (ripponden) limited Company Information

Company Number

04952659

Next Accounts

Oct 2025

Directors

Joseph Lubera

Alexander Lubera

View All

Shareholders

karen elizabeth lubera

joseph lubera

View All

Group Structure

View All

Industry

Dispensing chemist in specialised stores

Registered Address

first floor, rosemount house, huddersfield ro, elland, west yorkshire, HX5 0EE

Website

ryburn-pharmacy-pharmacy.business.site

ryburn pharmacy (ripponden) limited Estimated Valuation

£1.2m

Pomanda estimates the enterprise value of RYBURN PHARMACY (RIPPONDEN) LIMITED at £1.2m based on Net Assets of £595.9k and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Ryburn Pharmacy (ripponden) Limited is a live company located in elland, HX5 0EE with a Companies House number of 04952659. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in November 2003, it's largest shareholder is karen elizabeth lubera with a 40% stake. Ryburn Pharmacy (ripponden) Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.2m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Ryburn Pharmacy (Ripponden) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

3 Strong

3 Regular

6 Weak

Size

annual sales of £1.2m, make it smaller than the average company (£12.6m)

Growth

3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (7.4%)

EXPORT

Ryburn Pharmacy (Ripponden) Limited's latest turnover from January 2024 is estimated at £1.2 million and the company has net assets of £595.9 thousand. According to their latest financial statements, Ryburn Pharmacy (Ripponden) Limited has 11 employees and maintains cash reserves of £673.5 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Jan 2024	Jan 2023	Jan 2022	Jan 2021	Jan 2020	Jan 2019	Jan 2018	Jan 2017	Jan 2016	Jan 2015	Jan 2014	Jan 2013	Jan 2012	Jan 2011	Jan 2010
Turnover	1,155,323	1,127,687	1,430,489	1,350,888	1,110,098	1,476,099	1,138,533	1,123,130	1,180,506	1,117,642	1,010,753	1,331,262	1,360,192	1,385,985	1,340,940
Other Income Or Grants
Cost Of Sales	785,676	751,725	951,941	928,953	768,017	1,003,004	769,947	760,547	820,176	778,761	697,112	931,860	963,109	971,167	926,094
Gross Profit	369,646	375,962	478,548	421,935	342,081	473,095	368,586	362,583	360,330	338,881	313,641	399,403	397,082	414,817	414,847
Admin Expenses	405,241	416,965	426,515	379,713	351,738	512,760	367,819	380,818	277,355	290,735	263,821	289,015	318,761	368,489	40,894
Operating Profit	-35,595	-41,003	52,033	42,222	-9,657	-39,665	767	-18,235	82,975	48,146	49,820	110,388	78,321	46,328	373,953
Interest Payable
Interest Receivable	35,295	22,228	1,465	552	3,691	3,473	2,347	1,145	2,359	2,313	1,602	744	521	522	222
Pre-Tax Profit	-300	-18,775	53,499	42,774	-5,966	-36,192	3,115	-17,090	85,334	50,459	51,422	111,132	78,842	46,850	374,175
Tax			-10,165	-8,127			-592		-17,067	-10,596	-11,827	-26,672	-20,499	-13,118	-104,769
Profit After Tax	-300	-18,775	43,334	34,647	-5,966	-36,192	2,523	-17,090	68,267	39,863	39,595	84,460	58,343	33,732	269,406
Dividends Paid
Retained Profit	-300	-18,775	43,334	34,647	-5,966	-36,192	2,523	-17,090	68,267	39,863	39,595	84,460	58,343	33,732	269,406
Employee Costs	300,253	302,513	252,962	234,864	254,015	230,231	174,633	166,320	139,591	174,294	155,050	185,376	185,186	185,631	173,267
Number Of Employees	11	12	11	11	12	11	9	9	8	10	9	11	11	11	10
EBITDA*	-28,949	-33,786	59,722	49,435	-2,802	-32,847	8,041	-9,872	92,058	57,616	96,700	157,685	127,675	96,670	424,491

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Jan 2024	Jan 2023	Jan 2022	Jan 2021	Jan 2020	Jan 2019	Jan 2018	Jan 2017	Jan 2016	Jan 2015	Jan 2014	Jan 2013	Jan 2012	Jan 2011	Jan 2010
Tangible Assets	30,284	36,930	43,898	51,018	54,090	59,480	66,298	73,572	81,935	90,616	97,925	104,669	114,266	125,920	122,471
Intangible Assets												37,700	75,400	113,100	150,800
Investments & Other
Debtors (Due After 1 year)										12,500	12,500
Total Fixed Assets	30,284	36,930	43,898	51,018	54,090	59,480	66,298	73,572	81,935	103,116	110,425	142,369	189,666	239,020	273,271
Stock & work in progress	67,010	63,714	68,702	79,271	80,414	85,731	87,070	96,716	93,121	94,845	96,886	85,436	72,603	81,966	69,279
Trade Debtors	118,885	101,487	188,423	190,144	122,889	198,209	182,662	185,512	195,436	120,334	119,874	235,160	241,021	219,181	208,880
Group Debtors
Misc Debtors	30,378	36,636	33,952	20,731	21,137	34,528	23,770	20,766	32,841
Cash	673,483	671,084	599,068	573,157	531,222	453,032	472,979	465,963	449,980	493,658	431,624	209,055	88,470	120,035	88,946
misc current assets
total current assets	889,756	872,921	890,145	863,303	755,662	771,500	766,481	768,957	771,378	708,837	648,384	529,651	402,094	421,182	367,105
total assets	920,040	909,851	934,043	914,321	809,752	830,980	832,779	842,529	853,313	811,953	758,809	672,020	591,760	660,202	640,376
Bank overdraft
Bank loan
Trade Creditors	161,177	170,218	192,916	188,136	186,906	230,480	186,453	182,803	179,464	277,417	263,689	216,489	220,068	250,212	217,243
Group/Directors Accounts	93,463	92,327	46,941	45,288	34,263	19,263	18,463	22,763	23,243
other short term finances
hp & lease commitments
other current liabilities	65,333	47,204	74,543	103,815	46,171	32,476	42,296	53,268	48,620
total current liabilities	319,973	309,749	314,400	337,239	267,340	282,219	247,212	258,834	251,327	277,417	263,689	216,489	220,068	250,212	217,243
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities														95,339	141,563
provisions	4,120	3,855	4,621	5,394	5,371	5,754	6,368	7,019	8,220	9,037	9,484	9,588	10,209	11,511	12,162
total long term liabilities	4,120	3,855	4,621	5,394	5,371	5,754	6,368	7,019	8,220	9,037	9,484	9,588	10,209	106,850	153,725
total liabilities	324,093	313,604	319,021	342,633	272,711	287,973	253,580	265,853	259,547	286,454	273,173	226,077	230,277	357,062	370,968
net assets	595,947	596,247	615,022	571,688	537,041	543,007	579,199	576,676	593,766	525,499	485,636	445,943	361,483	303,140	269,408
total shareholders funds	595,947	596,247	615,022	571,688	537,041	543,007	579,199	576,676	593,766	525,499	485,636	445,943	361,483	303,140	269,408

	Jan 2024	Jan 2023	Jan 2022	Jan 2021	Jan 2020	Jan 2019	Jan 2018	Jan 2017	Jan 2016	Jan 2015	Jan 2014	Jan 2013	Jan 2012	Jan 2011	Jan 2010
Operating Activities
Operating Profit	-35,595	-41,003	52,033	42,222	-9,657	-39,665	767	-18,235	82,975	48,146	49,820	110,388	78,321	46,328	373,953
Depreciation	6,646	7,217	7,689	7,213	6,855	6,818	7,274	8,363	9,083	9,470	9,180	9,597	11,654	12,642	12,838
Amortisation											37,700	37,700	37,700	37,700	37,700
Tax			-10,165	-8,127			-592		-17,067	-10,596	-11,827	-26,672	-20,499	-13,118	-104,769
Stock	3,296	-4,988	-10,569	-1,143	-5,317	-1,339	-9,646	3,595	-1,724	-2,041	11,450	12,833	-9,363	12,687	69,279
Debtors	11,140	-84,252	11,500	66,849	-88,711	26,305	154	-21,999	95,443	460	-102,786	-5,861	21,840	10,301	208,880
Creditors	-9,041	-22,698	4,780	1,230	-43,574	44,027	3,650	3,339	-97,953	13,728	47,200	-3,579	-30,144	32,969	217,243
Accruals and Deferred Income	18,129	-27,339	-29,272	57,644	13,695	-9,820	-10,972	4,648	48,620
Deferred Taxes & Provisions	265	-766	-773	23	-383	-614	-651	-1,201	-817	-447	-104	-621	-1,302	-651	12,162
Cash flow from operations	-34,032	4,651	23,361	34,499	60,964	-24,220	8,968	15,318	-68,878	61,882	223,305	119,841	63,253	92,882	270,968
Investing Activities
capital expenditure		-249	-569	-4,141	-1,465				-402	-2,161	-2,436			-16,091	-323,809
Change in Investments
cash flow from investments		-249	-569	-4,141	-1,465				-402	-2,161	-2,436			-16,091	-323,809
Financing Activities
Bank loans
Group/Directors Accounts	1,136	45,386	1,653	11,025	15,000	800	-4,300	-480	23,243
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities													-95,339	-46,224	141,563
share issue											98				2
interest	35,295	22,228	1,465	552	3,691	3,473	2,347	1,145	2,359	2,313	1,602	744	521	522	222
cash flow from financing	36,431	67,614	3,118	11,577	18,691	4,273	-1,953	665	25,602	2,313	1,700	744	-94,818	-45,702	141,787
cash and cash equivalents
cash	2,399	72,016	25,911	41,935	78,190	-19,947	7,016	15,983	-43,678	62,034	222,569	120,585	-31,565	31,089	88,946
overdraft
change in cash	2,399	72,016	25,911	41,935	78,190	-19,947	7,016	15,983	-43,678	62,034	222,569	120,585	-31,565	31,089	88,946

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for ryburn pharmacy (ripponden) limited. Get real-time insights into ryburn pharmacy (ripponden) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for ryburn pharmacy (ripponden) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HX5 area or any other competitors across 12 key performance metrics.

RYBURN PHARMACY (RIPPONDEN) LIMITED group structure

Ryburn Pharmacy (Ripponden) Limited has no subsidiary companies.

Ultimate parent company

RYBURN PHARMACY (RIPPONDEN) LIMITED

04952659

RYBURN PHARMACY (RIPPONDEN) LIMITED Shareholders

karen elizabeth lubera	40%
joseph lubera	40%
gregory thomas lubera	10%
alexander joseph lubera	10%

Ryburn Pharmacy (Ripponden) Limited currently has 3 directors. The longest serving directors include Mr Joseph Lubera (Nov 2003) and Mr Alexander Lubera (Sep 2013).

officer	country	age	start	end	role
Mr Joseph Lubera	United Kingdom	65 years	Nov 2003	-	Director
Mr Alexander Lubera	United Kingdom	35 years	Sep 2013	-	Director
Mr Gregory Lubera	United Kingdom	33 years	Sep 2013	-	Director

P&L

January 2024

turnover

1.2m

+2%

operating profit

-35.6k

gross margin

32%

-4.03%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

January 2024

net assets

595.9k

total assets

920k

+0.01%

cash

673.5k

net assets

Total assets minus all liabilities

Similar Companies

medipharm (bradford) limited

4.5

middlestown enterprises limited

1.5

g.pennant roberts limited

a.p.a. (leicester) limited

3.5

d. & r. sharp (chemists) limited

4.5

company number

04952659

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

November 2003

ultimate parent company

None

previous names

N/A

address

first floor, rosemount house, huddersfield ro, elland, west yorkshire, HX5 0EE

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to ryburn pharmacy (ripponden) limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for RYBURN PHARMACY (RIPPONDEN) LIMITED. This can take several minutes, an email will notify you when this has completed.

ryburn pharmacy (ripponden) limited Company Information

ryburn pharmacy (ripponden) limited Estimated Valuation

ryburn pharmacy (ripponden) limited Estimated Valuation

ryburn pharmacy (ripponden) limited Estimated Valuation

Ryburn Pharmacy (ripponden) Limited Overview

Ryburn Pharmacy (ripponden) Limited Health Check

RYBURN PHARMACY (RIPPONDEN) LIMITED financials

ryburn pharmacy (ripponden) limited Credit Report and Business Information

Ryburn Pharmacy (ripponden) Limited Competitor Analysis

ryburn pharmacy (ripponden) limited Ownership

ryburn pharmacy (ripponden) limited directors

ryburn pharmacy (ripponden) limited company details

ryburn pharmacy (ripponden) limited Charges & Mortgages

ryburn pharmacy (ripponden) limited Capital Raised & Share Issues BETA

ryburn pharmacy (ripponden) limited Companies House Filings - See Documents